$13.79
Currently 13 wall-street analysts regularly analyze the financials of NovoCure Limited on a frequent basis to provide recommendations along with target share price. 13 analysts offering 12-month price forecasts for NovoCure Limited (NVCR) have a share price target of $24.07. This median of share price forecast represents a 74.56% upside from the latest price of $13.79 as on 17.01.26.
As per the chart shown above, analysts believe that the NovoCure Limited (NVCR) share price will touch around $24.07 in next 12-months.
Below is a chart showing the percentage difference between NovoCure Limited's share price and its median forecast price. As on 17.01.26, the difference is -52.88%
Based on 13 analysts tracking and researching NovoCure Limited (NVCR) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 5 | 5 | 5 |
| Outperform | 3 | 3 | 3 |
| Hold | 5 | 5 | 5 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |